(Q68070238)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3247321%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

title

The effects of carbidopa dose and time and route of administration on systemic L-dopa levels in rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3247321%20AND%20SRC:MED&resulttype=core&format=json

(S)-(−)-carbidopa monohydrate

21 September 2019

main subject

1 reference

P S Leppert

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3247321%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

M Cortese

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3247321%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

J A Fix

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3247321%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

publication date

1 September 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3247321%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

published in

Pharmaceutical Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3247321%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3247321%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3247321%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

page(s)

587-591

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3247321%20AND%20SRC:MED&resulttype=core&format=json

L-3,4-dihydroxyphenylalanine metabolism by the gut in vitro

21 September 2019

cites work

1 reference

12 December 2020

Blood-brain barrier to carbidopa (MK-486) and Ro 4-4602, peripheral dopa decarboxylase inhibitors

1 reference

12 December 2020

Effect of supplemental carbidopa on bioavailability of L-dopa

1 reference

12 December 2020

Carbidopa dosage modifies L-dopa induced side effects and blood levels of L-dopa and other amino acids in advanced parkinsonism

1 reference

12 December 2020

A method for the determination of some amino acid decarboxylases

1 reference

12 December 2020

Aromatic L-amino acid decarboxylase

1 reference

12 December 2020

The effect of an increased ratio of carbidopa to levodopa on the pharmacokinetics of levodopa

1 reference

12 December 2020

Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy

1 reference

12 December 2020

Interaction of L-alpha-methyl-alpha-hydrazino-3,4 dihydroxyphenylpropionic acid with dopa-decarboxylase from pig kidney

1 reference

12 December 2020

Inhibition of DOPA decarboxylase by the hydrazino analog of alpha-methylDOPA

1 reference

12 December 2020

The effect of carbidopa on the pharmacokinetics of intravenously administered levodopa: the mechanism of action in the treatment of parkinsonism.

1 reference

12 December 2020

Potentiation and inhbition of some central actions of L(-)-dopa by decarboxylase inhibitors

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1015946114321

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3247321%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

1 reference